Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rory Collins

Showing results (21-30 of 267) with videos related to

Pageof 27
Sort By:
BMJ (Clinical Research Ed.)|September 10, 2002
Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studiesFrançois Bonnici, Bernard Keavney, Rory Collins, et al.
Gastroenterology|April 17, 2021
Challenges and Opportunities in IBD Clinical Trial DesignMarla C Dubinsky, Rory Collins, Maria T Abreu, et al.
Circulation|December 9, 2024
Scientific and Clinical Impacts of UK Biobank in Cardiovascular MedicineAdam J Lewandowski, Martin K Rutter, Rory Collins
The New England Journal of Medicine|February 14, 2020
The Magic of Randomization versus the Myth of Real-World EvidenceRory Collins, Louise Bowman, Martin Landray, et al.
Science Translational Medicine|February 21, 2014
UK biobank data: come and get itNaomi E Allen, Cathie Sudlow, Tim Peakman, et al.
BMC Clinical Pharmacology|May 16, 2009
Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people, Jane Armitage, Louise Bowman, et al.
Lancet (London, England)|June 20, 2003
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trialRory Collins, Jane Armitage, Sarah Parish, et al.
Lancet (London, England)|June 15, 2020
Questioning statin therapy for older patients - Authors' replyJordan Fulcher, Anthony Keech, John Simes, et al.
Lancet (London, England)|March 16, 2004
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditionsRory Collins, Jane Armitage, Sarah Parish, et al.
Lancet (London, England)|December 21, 2002
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesSarah Lewington, Robert Clarke, Nawab Qizilbash, et al.
Pageof 27

Showing results (21-30 of 267) with videos related to

Sort By:
Pageof 27
BMJ (Clinical Research Ed.)|September 10, 2002
Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studiesFrançois Bonnici, Bernard Keavney, Rory Collins, et al.
Gastroenterology|April 17, 2021
Challenges and Opportunities in IBD Clinical Trial DesignMarla C Dubinsky, Rory Collins, Maria T Abreu, et al.
Circulation|December 9, 2024
Scientific and Clinical Impacts of UK Biobank in Cardiovascular MedicineAdam J Lewandowski, Martin K Rutter, Rory Collins
The New England Journal of Medicine|February 14, 2020
The Magic of Randomization versus the Myth of Real-World EvidenceRory Collins, Louise Bowman, Martin Landray, et al.
Science Translational Medicine|February 21, 2014
UK biobank data: come and get itNaomi E Allen, Cathie Sudlow, Tim Peakman, et al.
BMC Clinical Pharmacology|May 16, 2009
Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people, Jane Armitage, Louise Bowman, et al.
Lancet (London, England)|June 20, 2003
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trialRory Collins, Jane Armitage, Sarah Parish, et al.
Lancet (London, England)|June 15, 2020
Questioning statin therapy for older patients - Authors' replyJordan Fulcher, Anthony Keech, John Simes, et al.
Lancet (London, England)|March 16, 2004
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditionsRory Collins, Jane Armitage, Sarah Parish, et al.
Lancet (London, England)|December 21, 2002
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesSarah Lewington, Robert Clarke, Nawab Qizilbash, et al.
Pageof 27